Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.3.1; removed Lung cancer and related topics (MedlinePlus Genetics) and Revision: v3.2.0.
    Difference
    0.2%
    Check dated 2025-11-24T14:44:19.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Lung cancer and related topics were added to the related topics section, and a government funding notice was removed. These changes affect navigation and contextual information rather than the core study details.
    Difference
    0.6%
    Check dated 2025-11-17T07:10:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's related topics section was updated to remove Lung cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-03T01:23:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic focusing on lung cancer, expanding core health/genetics content.
    Difference
    0.2%
    Check dated 2025-10-19T16:33:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version bump to v3.2.0; a specific MedlinePlus Genetics topic (Lung cancer) was removed.
    Difference
    3%
    Check dated 2025-10-05T10:29:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.